CN109988177B - Pyrazole structure-containing N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition derivative and preparation method and application thereof - Google Patents

Pyrazole structure-containing N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition derivative and preparation method and application thereof Download PDF

Info

Publication number
CN109988177B
CN109988177B CN201910362672.XA CN201910362672A CN109988177B CN 109988177 B CN109988177 B CN 109988177B CN 201910362672 A CN201910362672 A CN 201910362672A CN 109988177 B CN109988177 B CN 109988177B
Authority
CN
China
Prior art keywords
substituted maleimide
methoxyphenyl
terpinene cycloaddition
alpha
terpinene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201910362672.XA
Other languages
Chinese (zh)
Other versions
CN109988177A (en
Inventor
王玮
邓莉平
杨群
张娜
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Puzhong Discovery Pharmaceutical Technology Shanghai Co ltd
Original Assignee
Shaoxing University Yuanpei College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shaoxing University Yuanpei College filed Critical Shaoxing University Yuanpei College
Priority to CN201910362672.XA priority Critical patent/CN109988177B/en
Publication of CN109988177A publication Critical patent/CN109988177A/en
Application granted granted Critical
Publication of CN109988177B publication Critical patent/CN109988177B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The invention discloses a pyrazole structure-containing N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition derivative, a preparation method and application thereof, wherein 1-isopropyl-4-methyl-bicyclo [2,2,2] oct-5-ene-2, 3-dicarboxylic anhydride and p-methoxyaniline are respectively dissolved in an acetone solvent, p-methoxyaniline solution is dripped into a reaction bottle containing 1-isopropyl-4-methyl-bicyclo [2,2,2] oct-5-ene-2, 3-dicarboxylic anhydride solution under stirring to prepare an N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition product, then the N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition product and 6-fluorochromone phenylhydrazone are mixed in absolute ethanol, the N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition derivative containing pyrazole structure prepared by adding chloramine T has stronger inhibitory activity to HO8901, HL-60 and ECA109, and provides a foundation for the development and research of potential drugs.

Description

Pyrazole structure-containing N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition derivative and preparation method and application thereof
Technical Field
The invention belongs to the technical field of medicines, and particularly relates to an N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition derivative containing a pyrazole structure, and a preparation method and application thereof.
Background
The chemical structural formula of the N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition derivative is shown in figure 1. The 1, 3-dipolar cycloaddition reaction is the most important method for synthesizing five-membered heterocyclic compounds with good regioselectivity and body selectivity, and is also a more active reaction in heterocyclic pharmaceutical chemistry research.
In recent years, chromones have received much attention due to a wide range of biological activities, such as anticancer, antibacterial, inhibition of platelet aggregation, and the like. Therefore, the heterocyclic compound has high synthetic value in terms of pharmacology and synthesis angle. Pyrazole derivatives have attracted considerable attention as a class of useful intermediates and as a variety of pharmaceutical activities that they themselves exhibit.
The influence of different heterocycles on the pharmacological activity caused by the aggregation of the same molecule is researched, the pyrazole N-p-methoxyphenyl maleimide alpha-terpinene cycloaddition derivative containing the chromone structure is synthesized through the dipolar cycloaddition reaction, and the method has important significance in the field of medicine research.
Disclosure of Invention
The invention aims to provide an N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition derivative containing a pyrazole structure, and a preparation method and application thereof.
In order to achieve the purpose, the technical scheme of the invention is as follows:
the N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition derivative containing a pyrazole structure has the following chemical structural formula:
Figure GDA0002850018170000021
the invention discloses a preparation method of a pyrazole structure-containing N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition derivative, which is characterized in that the preparation method of the pyrazole structure-containing N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition derivative comprises the following steps:
respectively dissolving 1-isopropyl-4-methyl-bicyclo [2,2,2] oct-5-ene-2, 3-dicarboxylic anhydride and p-anisidine in an acetone solvent, dropwise adding a p-anisidine solution into a reaction bottle containing a 1-isopropyl-4-methyl-bicyclo [2,2,2] oct-5-ene-2, 3-dicarboxylic anhydride solution under stirring, carrying out reaction heat release to gradually generate a light yellow precipitate, reacting at room temperature for 1-2 hours, sequentially adding manganese acetate, triethylamine and acetic anhydride into the reaction bottle, heating the reaction, gradually dissolving the precipitate, reacting at 50-60 ℃ for 5-8 hours, changing the solution from orange yellow to red black, cooling to room temperature, washing the precipitate with water, drying in a large amount, and recrystallizing with acetone to obtain a product N-p-methoxyphenyl-substituted maleimide alpha-terpinene cycloaddition product (ii) a
Mixing the N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition product and 6-fluorochromone phenylhydrazone in absolute ethyl alcohol, adding chloramine T, refluxing for 12-15 hours, carrying out addition reaction, recrystallizing with methanol, and drying in vacuum to obtain the pyrazole structure-containing N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition derivative.
Further, the dissolving of 1-isopropyl-4-methyl-bicyclo [2,2,2] oct-5-ene-2, 3-dicarboxylic anhydride (compound 1) and p-anisidine (compound 2) in acetone solvent, respectively, comprises:
adding 2mmol of 1-isopropyl-4-methyl-bicyclo [2,2,2] oct-5-ene-2, 3-dicarboxylic anhydride into 20-30 mL of acetone solvent;
adding 2mmol of p-anisidine into 20-30 mL of acetone solvent.
Further, the molar ratio of the N-p-methoxyphenyl-substituted maleimide α -terpinene cycloaddition product, 6-fluorochromone phenylhydrazone, and chloramine T is 1: 1: 1-1.5.
Further, the sequentially adding manganese acetate, triethylamine and acetic anhydride comprises:
adding 0.3-0.5 g of manganese acetate into 40-60 mL of acetone solvent;
adding 15-20mL of triethylamine into 40-60 mL of acetone solvent;
30-35mL of acetic anhydride is added into 40-60 mL of acetone solvent.
Further, the N-p-methoxyphenyl substituted maleimide α -terpinene cycloaddition product and 6-fluorochromone phenylhydrazone are mixed in anhydrous ethanol, wherein 1mmol of the N-p-methoxyphenyl substituted maleimide α -terpinene cycloaddition product and 1mmol of 6-fluorochromone phenylhydrazone are added in every 20-25mL of the anhydrous ethanol.
The invention also provides application of the pyrazole structure-containing N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition derivative in preparation of antitumor drugs.
The invention provides an N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition derivative containing a pyrazole structure, a preparation method and application thereof, wherein the structure of chromone is introduced on the basis of introducing a five-membered pyrazole ring structure into an N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition product, so that the pharmacological activity can be changed, 6-fluoro chromone phenylhydrazone substituted by formaldehyde group at the 3-position is used for substituting on the structure of pyrazole, the N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition product is structurally transformed, and the prepared N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition derivative containing the pyrazole structure has stronger inhibitory activity on HO8901 (ovarian cancer cells), HL-60 (leukemia cells) and ECA109 (intestinal cancer cells), provides a foundation for the development and research of the compound for potential drugs.
Drawings
FIG. 1 is a chemical structural formula of a cycloaddition derivative of N-p-methoxyphenyl substituted maleimide alpha-terpinene;
FIG. 2 is a chemical structural formula of the pyrazole-containing N-p-methoxyphenyl-substituted maleimide alpha-terpinene cycloaddition derivative;
FIG. 3 is a chemical formula schematic diagram of a preparation method of the pyrazole structure-containing N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition derivative.
Detailed Description
The technical solutions of the present invention are further described in detail below with reference to the drawings and examples, which should not be construed as limiting the present invention.
Researches show that the pharmacological activity can be changed by introducing the structure of chromone on the basis of introducing a five-membered pyrazole ring structure into an N-p-methoxyphenyl maleimide alpha-terpinene cycloaddition product. The experimental data are as follows:
Figure GDA0002850018170000041
TABLE 1
Based on the above experimental data, the structural modification of the N-p-methoxyphenyl maleimide α -terpinene cycloaddition product was carried out using 6-fluorochromone phenylhydrazone substituted with formaldehyde group at the 3-position in the present application for substitution on the pyrazole structure.
The chemical structural formula of the pyrazole-structure-containing N-p-methoxyphenyl-substituted maleimide alpha-terpinene cycloaddition derivative is shown in figure 2.
In one embodiment, a method for preparing an N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition derivative containing a pyrazole structure comprises the following steps:
respectively dissolving 1-isopropyl-4-methyl-bicyclo [2,2,2] oct-5-ene-2, 3-dicarboxylic anhydride (compound 1) and p-anisidine (compound 2) in an acetone solvent, dropwise adding the p-anisidine solution (compound 2) into a reaction bottle containing the 1-isopropyl-4-methyl-bicyclo [2,2,2] oct-5-ene-2, 3-dicarboxylic anhydride (compound 1) solution under stirring, discharging heat and gradually generating light yellow precipitates, reacting at room temperature for 1-2 hours, sequentially adding manganese acetate, triethylamine and acetic anhydride into the reaction bottle, reacting for 1-2 hours, heating, gradually dissolving the precipitates, reacting at 50-60 ℃ for 5-8 hours, changing the solution from orange yellow to red black, cooling to room temperature, washing the precipitate with a large amount of water, drying, and recrystallizing with acetone to obtain the product N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition product (compound 3);
mixing the N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition product (compound 3) and 6-fluorochromone phenylhydrazone (compound 4) in absolute ethyl alcohol, adding chloramine T, refluxing for 12-15 hours, carrying out addition reaction, recrystallizing with methanol, and drying in vacuum to obtain the pyrazole structure-containing N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition derivative (compound 5).
Wherein the chemistry of compound 3 is collectively referred to as: 1-isopropyl-4-methyl-bicyclo [2,2,2] -5-octene-2, 3- (N-p-methoxyphenyl) dicarboxyl, abbreviated in this example as N-p-methoxyphenyl-substituted maleimide α -terpinene cycloaddition product.
While the chemistry of compound 5 is collectively referred to as: 3- (6-fluoro-chromon-3-yl) -1-phenyl-7-methyl-4-isopropyl-bicyclo [2,2,2] octa [2,3-d ]3aH,7aH pyrazole-2, 3- (N-p-methoxyphenyl) dicarboximide, referred to in this example as the pyrazole-containing N-p-methoxyphenyl-substituted maleimide α -terpinene cycloaddition derivative.
Wherein, the synthesis of the 6-fluorochromone phenylhydrazone (compound 4) can be synthesized by a method of generating Schiff base by dehydration reaction of 6-fluorochromone with substituted formaldehyde group at the 3 position and phenylhydrazine.
Example 1, 2mmol phenylhydrazine was added to a flask containing 10mL tetrahydrofuran, and the mixture was stirred under reflux in a boiling water bath until dissolved, then 20mL absolute ethanol solution in which 2mmol of 6-fluorochromone substituted with a formaldehyde group at the 3-position was dissolved was slowly added dropwise, and the mixture was stirred under reflux in a boiling water bath for 1 hour, and 10 drops of hydrochloric acid were added dropwise, and a pale yellow precipitate appeared. And (3) refluxing and stirring in a continuous boiling water bath for 5 hours, stopping the water bath, adding 20mL of distilled water, stirring, deepening the color of a light yellow precipitate, and performing suction filtration to obtain a yellow-red needle-shaped product of 6-fluorochromone phenylhydrazone. Washing with anhydrous ether for several times, and vacuum drying to obtain the product 6-fluorochromone phenylhydrazone (compound 4).
The present invention is not limited to the method for synthesizing 6-fluorochromone phenylhydrazone (compound 4), and the chemical name of compound 4 may be expressed as: 6-fluoro-chromone-3-phenylhydrazone, which is not described in detail herein.
In one example, 1-isopropyl-4-methyl-bicyclo [2,2,2] oct-5-ene-2, 3-dicarboxylic anhydride (compound 1) and p-anisidine (compound 2) are each dissolved in an acetone solvent comprising:
adding 2mmol of 1-isopropyl-4-methyl-bicyclo [2,2,2] oct-5-ene-2, 3-dicarboxylic anhydride into 20-30 mL of acetone solvent;
adding 2mmol of p-anisidine into 20-30 mL of acetone solvent.
In one embodiment, the molar ratio of the N-p-methoxyphenyl-substituted maleimide α -terpinene cycloaddition product, 6-fluorochromone phenylhydrazone, and chloramine T is 1: 1: 1-1.5.
In one embodiment, manganese acetate, triethylamine and acetic anhydride are added sequentially, including:
adding 0.3-0.5 g of manganese acetate into 40-60 mL of acetone solvent;
adding 15-20mL of triethylamine into 40-60 mL of acetone solvent;
30-35mL of acetic anhydride is added into 40-60 mL of acetone solvent.
In one example, the N-p-methoxyphenyl-substituted maleimide α -terpinene cycloaddition product and 6-fluorochromone phenylhydrazone are mixed in anhydrous ethanol, wherein 1mmol of the N-p-methoxyphenyl-substituted maleimide α -terpinene cycloaddition product and 1mmol of 6-fluorochromone phenylhydrazone are added per 20-25mL of anhydrous ethanol.
The preparation of the N-p-methoxyphenyl-substituted maleimide α -terpinene cycloaddition derivative containing the pyrazole structure (Compound 5) of the present application is illustrated in detail by the following specific examples:
examples 2,
1) And synthesis of N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition product: respectively dissolving 2mmol of 1-isopropyl-4-methyl-bicyclo [2,2,2] oct-5-ene-2, 3-dicarboxylic anhydride (compound 1) and 2mmol of p-anisidine (compound 2) in 20mL of acetone solvent, dropwise adding the p-anisidine solution into a reaction bottle containing the 1-isopropyl-4-methyl-bicyclo [2,2,2] oct-5-ene-2, 3-dicarboxylic anhydride (compound 1) solution under stirring, reacting at room temperature for 1 hour while gradually generating light yellow precipitate, sequentially adding 0.3 g of manganese acetate, 15mL of triethylamine and 30mL of acetic anhydride into the reaction bottle, reacting at the temperature while gradually dissolving the precipitate, reacting at 50-60 ℃ for 5 hours while changing the solution from orange yellow to red black, cooling to room temperature, washing the precipitate with a large amount of water, drying, and recrystallizing with acetone to obtain the product N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition product (compound 3).
2) Introduction of a pyrazole structure: mixing 1mmol of N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition product (compound 3) and 1mmol of 6-fluorochromone phenylhydrazone (compound 4) in 20mL of absolute ethyl alcohol, adding 1.2mmol of chloramine T, refluxing for 12 hours, performing addition reaction, recrystallizing with methanol, and drying in vacuum to obtain the pyrazole structure-containing N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition derivative (compound 5).
Examples 3,
1) And synthesis of N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition product: respectively dissolving 2mmol of 1-isopropyl-4-methyl-bicyclo [2,2,2] oct-5-ene-2, 3-dicarboxylic anhydride (compound 1) and 2mmol of p-anisidine (compound 2) in 30mL of acetone solvent, dropwise adding the p-anisidine solution into a reaction bottle containing the 1-isopropyl-4-methyl-bicyclo [2,2,2] oct-5-ene-2, 3-dicarboxylic anhydride (compound 1) solution under stirring, reacting at room temperature for 2 hours, then sequentially adding 0.5 g of manganese acetate, 20mL of triethylamine and 35mL of acetic anhydride into the reaction bottle, reacting at the temperature of 50-60 ℃ for 8 hours until the solution turns into red black from orange, cooling to room temperature, washing the precipitate with a large amount of water, drying, and recrystallizing with acetone to obtain the product N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition product (compound 3).
2) Introduction of a pyrazole structure: mixing 1mmol of N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition product (compound 3) and 1mmol of 6-fluorochromone phenylhydrazone (compound 4) in 25mL of absolute ethyl alcohol, adding 1.5mmol of chloramine T, refluxing for 15 hours, carrying out addition reaction, recrystallizing with methanol, and drying in vacuum to obtain the pyrazole structure-containing N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition derivative (compound 5).
Examples 4,
1) And synthesis of N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition product: respectively dissolving 2mmol of 1-isopropyl-4-methyl-bicyclo [2,2,2] oct-5-ene-2, 3-dicarboxylic anhydride (compound 1) and 2mmol of p-anisidine (compound 2) in 25mL of acetone solvent, dropwise adding the p-anisidine solution into a reaction bottle containing the 1-isopropyl-4-methyl-bicyclo [2,2,2] oct-5-ene-2, 3-dicarboxylic anhydride (compound 1) solution under stirring, reacting at room temperature for 2 hours, then sequentially adding 0.4 g of manganese acetate, 18mL of triethylamine and 33mL of acetic anhydride into the reaction bottle, reacting at the temperature of 50-60 ℃ for 6 hours until the solution turns into red black from orange, cooling to room temperature, washing the precipitate with a large amount of water, drying, and recrystallizing with acetone to obtain the product N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition product (compound 3).
2) Introduction of a pyrazole structure: mixing 1mmol of N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition product (compound 3) and 1mmol of 6-fluorochromone phenylhydrazone (compound 4) in 25mL of absolute ethyl alcohol, adding 1.4mmol of chloramine T, refluxing for 13 hours, performing addition reaction, recrystallizing with methanol, and drying in vacuum to obtain the pyrazole structure-containing N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition derivative (compound 5).
Figure 3 shows the preparation of compound 5 of the present application, wherein 1 represents compound 1, 2 represents compound 2,3 represents compound 3, 4 represents compound 4, and 5 represents compound 5.
The experimental data are as follows:
the N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition derivative (compound 5) containing pyrazole structure is light yellow crystal, the yield is 46.5 percent, and the m.p.164-165 ℃.
1H NMR(DMSO)δ:7.245-7.502(m,12H,Ar-H),6.47(s,1H,C＝C-H),6.01(d,J＝8.5Hz,1H,H-5),6.09(1H,d,J＝8.5Hz,1H,H-6),3.78(s,3H,OCH3),3.13(1H,d,J＝8.9Hz,1H H-2),2.85(1H,d,J＝8.9Hz,1H,H-3),1.33(1H,m,H-7a),1.47(1H,m,H-7b),1.33(1H,m,H-8a),1.47(1H,m,H-8b),2.56(1H,m,H-9),1.01(3H,d,J＝7.0Hz,H-10),1.08(3H,d,J＝6.7Hz,H-11),1.50(3H,s,H-12).
IR 3457(N-C＝O),3082(ArH),1720(C＝O),1573(C＝N),1294(C-O-C)cm-1
m/e:619(100.0％)。
Anal.calcd.for C37H34FN3O5：C,71.71；H,5.53；N,6.78。
The result of measuring the antitumor activity of the pyrazole-containing N-p-methoxyphenyl-substituted maleimide alpha-terpinene cycloaddition derivative (compound 5) is as follows:
MTT assay compound 5 was tested for in vitro inhibition of different tumor strains:
compound 5 was dissolved and diluted in DMSO, and tumor cells Bel-7402 (human liver cancer cells), KB (oral cancer cells), SGC7901 (gastric cancer cells), HO8901 (ovarian cancer cells), HL-60 (leukemia cells), ECA109 (intestinal cancer cells) were seeded in 4000/200. mu.L/well in 96-well plates, 2. mu.L of compound was added to each well to a final concentration of 12.0. mu.M, 6.0. mu.M, 3.0. mu.M, 1.5. mu.M, and incubated in a 37 ℃ 5% CO2 cell incubator for 72 hours with DMSO (1%) as a blank. After 72 hours, MTT was added to a final concentration of 0.25mg/mL, the mixture was placed in a 5% CO2 cell incubator at 37 ℃ for 4 hours, the solvent was then blotted, 100. mu.l DMSO was added to each well, and the absorbance (OD value) was measured at 570nm using an enzyme-linked immunosorbent assay, and the data obtained was used to calculate the IC50 value. Selecting compounds with high inhibitory activity, and determining the influence of different action times of the compounds at different concentrations on the human tumor cell cycle and apoptosis.
The test compounds at various concentrations were coarse-screened in 96-well plates and, based on the resulting inhibition, IC50 values were calculated and the results are shown in the following table:
Figure GDA0002850018170000091
TABLE 2
Table 2 shows the IC of N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition derivative (compound 5) containing pyrazole structure on six tumor cell strains50The results show that the pyrazole structure-containing N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition derivative (compound 5) has stronger inhibitory activity on HO8901 (ovarian cancer cells), HL-60 (leukemia cells) and ECA109 (intestinal cancer cells), and provides a foundation for the development and research of potential drugs.
The above embodiments are only for illustrating the technical solution of the present invention and not for limiting the same, and those skilled in the art can make various corresponding changes and modifications according to the present invention without departing from the spirit and the essence of the present invention, but these corresponding changes and modifications should fall within the protection scope of the appended claims.

Claims (7)

1. The pyrazole structure-containing N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition derivative is characterized in that the chemical structural formula of the pyrazole structure-containing N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition derivative is as follows:
Figure FDA0002850018160000011
2. the process for preparing the pyrazole structure-containing N-p-methoxyphenyl-substituted maleimide α -terpinene cycloaddition derivative according to claim 1, wherein the process for preparing the pyrazole structure-containing N-p-methoxyphenyl-substituted maleimide α -terpinene cycloaddition derivative comprises:
respectively dissolving 1-isopropyl-4-methyl-bicyclo [2,2,2] oct-5-ene-2, 3-dicarboxylic anhydride and p-anisidine in an acetone solvent, dropwise adding a p-anisidine solution into a reaction bottle containing a 1-isopropyl-4-methyl-bicyclo [2,2,2] oct-5-ene-2, 3-dicarboxylic anhydride solution under stirring, carrying out reaction heat release to gradually generate a light yellow precipitate, reacting at room temperature for 1-2 hours, sequentially adding manganese acetate, triethylamine and acetic anhydride into the reaction bottle, heating the reaction, gradually dissolving the precipitate, reacting at 50-60 ℃ for 5-8 hours, changing the solution from orange yellow to red black, cooling to room temperature, washing the precipitate with water, drying in a large amount, and recrystallizing with acetone to obtain a product N-p-methoxyphenyl-substituted maleimide alpha-terpinene cycloaddition product (ii) a
Mixing the N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition product and 6-fluorochromone phenylhydrazone in absolute ethyl alcohol, adding chloramine T, refluxing for 12-15 hours, carrying out addition reaction, recrystallizing with methanol, and drying in vacuum to obtain the pyrazole structure-containing N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition derivative;
wherein the chemical structural formula of the N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition product is as follows:
Figure FDA0002850018160000021
the chemical structural formula of the 6-fluorochromone phenylhydrazone is as follows:
Figure FDA0002850018160000022
3. the method for preparing the pyrazole structure-containing N-p-methoxyphenyl-substituted maleimide α -terpinene cycloaddition derivative according to claim 2, wherein the dissolving of 1-isopropyl-4-methyl-bicyclo [2,2,2] oct-5-ene-2, 3-dicarboxylic anhydride and p-anisidine in an acetone solvent comprises:
adding 2mmol of 1-isopropyl-4-methyl-bicyclo [2,2,2] oct-5-ene-2, 3-dicarboxylic anhydride into 20-30 mL of acetone solvent;
adding 2mmol of p-anisidine into 20-30 mL of acetone solvent.
4. The method for preparing the pyrazole-containing N-p-methoxyphenyl-substituted maleimide alpha-terpinene cycloaddition derivative according to claim 2, wherein the molar ratio of the N-p-methoxyphenyl-substituted maleimide alpha-terpinene cycloaddition product, 6-fluorochromone phenylhydrazone, and chloramine T is 1: 1: 1-1.5.
5. The method for preparing the pyrazole structure-containing N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition derivative according to claim 2, wherein the sequentially adding manganese acetate, triethylamine and acetic anhydride comprises:
adding 0.3-0.5 g of manganese acetate into 40-60 mL of acetone solvent;
adding 15-20mL of triethylamine into 40-60 mL of acetone solvent;
30-35mL of acetic anhydride is added into 40-60 mL of acetone solvent.
6. The method for preparing the N-p-methoxyphenyl substituted maleimide α -terpinene cycloaddition derivative having pyrazole structure according to claim 2, wherein the N-p-methoxyphenyl substituted maleimide α -terpinene cycloaddition product and 6-fluorochromone phenylhydrazone are mixed in anhydrous ethanol, wherein 1mmol of the N-p-methoxyphenyl substituted maleimide α -terpinene cycloaddition product and 1mmol of the 6-fluorochromone phenylhydrazone are added to 20-25mL of the anhydrous ethanol.
7. The use of the pyrazole structure-containing N-p-methoxyphenyl-substituted maleimide α -terpinene cycloaddition derivative according to claim 1 in the preparation of an antitumor medicament.
CN201910362672.XA 2019-04-30 2019-04-30 Pyrazole structure-containing N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition derivative and preparation method and application thereof Active CN109988177B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910362672.XA CN109988177B (en) 2019-04-30 2019-04-30 Pyrazole structure-containing N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition derivative and preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910362672.XA CN109988177B (en) 2019-04-30 2019-04-30 Pyrazole structure-containing N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition derivative and preparation method and application thereof

Publications (2)

Publication Number Publication Date
CN109988177A CN109988177A (en) 2019-07-09
CN109988177B true CN109988177B (en) 2021-08-24

Family

ID=67135838

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910362672.XA Active CN109988177B (en) 2019-04-30 2019-04-30 Pyrazole structure-containing N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition derivative and preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN109988177B (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002076989A1 (en) * 2001-03-23 2002-10-03 The University Of Newcastle Research Associates Limited Protein phosphate inhibitors
CN103896954A (en) * 2013-11-15 2014-07-02 绍兴文理学院 Pyrazol norcantharidin derivative as well as preparation method and application thereof
CN106397445A (en) * 2016-04-29 2017-02-15 绍兴文理学院 Pyrazoles N-p-bromophenyl maleimide derivative containing chromone structure as well as preparation method and application thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002076989A1 (en) * 2001-03-23 2002-10-03 The University Of Newcastle Research Associates Limited Protein phosphate inhibitors
CN103896954A (en) * 2013-11-15 2014-07-02 绍兴文理学院 Pyrazol norcantharidin derivative as well as preparation method and application thereof
CN106397445A (en) * 2016-04-29 2017-02-15 绍兴文理学院 Pyrazoles N-p-bromophenyl maleimide derivative containing chromone structure as well as preparation method and application thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
新型含色酮异噁唑类去甲斑蝥素衍生物的合成;黄文盈，等;《绍兴文理学院学报》;20150331;第35卷(第7期);10-13页 *

Also Published As

Publication number Publication date
CN109988177A (en) 2019-07-09

Similar Documents

Publication Publication Date Title
CN108570086B (en) Maleimide derivatives of the triazole structure containing arabinose and the preparation method and application thereof
CN111269228B (en) Preparation method of indolizine ring-1, 2-diketone and derivative thereof with fluorescence activity
CN109988177B (en) Pyrazole structure-containing N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition derivative and preparation method and application thereof
CN110003224B (en) Pyrazole structure-containing N-p-methylphenyl substituted maleimide alpha-terpinene cycloaddition derivative and preparation method and application thereof
CN110105364B (en) Pyrazole structure-containing N-p-chlorophenyl substituted maleimide alpha-terpinene cycloaddition derivative, and preparation method and application thereof
CN109988178B (en) Pyrazole structure-containing N-p-nitrophenyl substituted maleimide alpha-terpinene cycloaddition derivative and preparation method and application thereof
CN109988176B (en) Pyrazole structure-containing N-p-bromophenyl substituted maleimide alpha-terpinene cycloaddition derivative and preparation method and application thereof
CN109988179B (en) Pyrazole structure-containing N-phenyl substituted maleimide alpha-terpinene cycloaddition derivative and preparation method and application thereof
CN110128444B (en) P-nitrophenyl substituted chromone structure-containing spiro [ indazole-isoxazole ] derivative, and preparation method and application thereof
CN111303027A (en) Fluroxacin acrylketone derivative and preparation method and application thereof
CN107698571B (en) Naphthalimide-coumarin DNA targeting double-intercalator, synthesis and application thereof
CN108947916B (en) Perimidine quinone derivative and preparation method and application thereof
CN109180583B (en) Synthesis and application of naphthalimide derivative containing heterocyclic sulfone group and N-oxide
CN112225745B (en) Isopilasin compound with anti-tumor activity, preparation method and application
CN108570085B (en) Maleimide derivatives of the triazole structure containing xylose and the preparation method and application thereof
CN108558968B (en) Maleimide derivatives of the triazole structure containing glucose and the preparation method and application thereof
CN110804039B (en) Phthalimide-containing 1, 8-naphthalic anhydride derivatives, pharmaceutically acceptable salts thereof and application of anti-tumor drugs thereof
CN110183467B (en) P-methoxyphenyl substituted chromone structure-containing spiro [ indazole-isoxazole ] derivative, and preparation method and application thereof
CN116199687B (en) Beta-carboline-3-position connected 1,2, 3-triazole compound as well as preparation method and application thereof
CN110759920A (en) P-methoxyphenyl substituted spiro [ indazole-pyrazoline ] derivative containing pyrazole structure and preparation method and application thereof
CN106046019B (en) A kind of Valine ring substituent norcantharidin derivative and the preparation method and application thereof
CN106188081B (en) A kind of D-Val ring substituent norcantharidin derivative and the preparation method and application thereof
CN108570087B (en) Maleimide derivatives of the triazole structure containing galactolipin and the preparation method and application thereof
CN114920684B (en) Selenium-containing benzamide compound and synthetic method and application thereof
CN103739566B (en) Containing the chirality five-membered of sulphonamide and ring framework compound and preparation method and purposes

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20220705

Address after: 250000 1422, building n, Hengda City, No. 58, Gongye North Road, Licheng District, Jinan City, Shandong Province

Patentee after: Jinan Weiyang Technology Co.,Ltd.

Address before: No. 2799, Qunxian Middle Road, Shaoxing City, Zhejiang Province

Patentee before: SHAOXING UNIVERSITY YUANPEI College

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20221227

Address after: 101, 201, 301, 401, Unit 10, No. 159, Tianzhou Road, Xuhui District, Shanghai 200000

Patentee after: Puzhong discovery Pharmaceutical Technology (Shanghai) Co.,Ltd.

Address before: 250000 1422, building n, Hengda City, No. 58, Gongye North Road, Licheng District, Jinan City, Shandong Province

Patentee before: Jinan Weiyang Technology Co.,Ltd.

TR01 Transfer of patent right